Axiom Frontier is committed to financial transparency.
Our operations are funded through a combination of licensing revenue and private investment.
The licensing revenue derives from intellectual property developed by our founder during his early career in pharmaceutical chemistry. The relevant patents are a matter of public record and are available through the standard federal filing systems, should anyone wish to locate them, which has not so far proven necessary.
The private investment component consists of investment that is private.
Axiom Frontier accepts no government funding, no corporate sponsorships, and no advertising revenue. This independence is essential to our mission: our researchers answer to the data, to their group leads, and to a monthly call with the Director, in that order.
A detailed annual financial report was considered at the 2022 symposium and the minutes of that consideration are available upon request.*
* Requests are processed by the Office of the Director. Processing times vary. Current average: indefinite.